Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older (men and women)
- People who have signed a consent form agreeing to participate
- People whose vision prescription (short-sightedness, long-sightedness, or astigmatism) is below 3 diopters
- People who are able and willing to follow the study instructions
For healthy volunteers:
- People with no eye conditions or abnormalities found during an eye examination
For people with Primary Open Angle Glaucoma (POAG):
- People who have been diagnosed with a type of glaucoma called Primary Open Angle Glaucoma
- People whose glaucoma has caused a level of vision field loss measured at 10 decibels (dB) or less (confirm with trial site)
For people with Age-Related Macular Degeneration (AMD):
- People who have been diagnosed with the "dry" form of age-related macular degeneration
- People whose dry AMD has been classified as Stage II or Stage III
Who may not be able to join:
- People who have eye abnormalities that would prevent accurate measurements being taken
- People who have eye inflammation or other eye conditions that could interfere with the study
- People who have taken certain light-sensitive medications in the 3 months before the study (confirm which medications apply with the trial site)
- People who have a condition that may cause sensitivity to light, including lupus (SLE), Porphyria, Vitiligo, Xeroderma Pigmentosum, or Albinism
- People who have any form of epilepsy
- People who have had eye surgery in the 3 months before the study
- People who are pregnant, planning to become pregnant, or currently breastfeeding
- People who have a serious ongoing or recent medical or surgical illness or disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Doreen Schmidl, MD,PhD, Department of Clinical Pharmacology, Medical University of Vienna
Phone: 0043140400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Light stimulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.